Indaptus Therapeutics, Inc. (NASDAQ:INDP) Financings
Financings
| Raise | Date |
|---|---|
| Private placement of non-voting convertible preferred stock Closed: US$6M raised Buyers: David E. Lazar ($6.0 million investment for 300,000 Series AA and 700,000 Series AAA preferred shares; appointed Co-CEO and Chairman) | Dec 30, 2025 |
| Private placement of convertible promissory notes and accompanying warrants Tranche closed: US$5.7M raised · Warrants to purchase 200% of the conversion shares, issued following conversion of the… · Paulson Investment Company, LLC Dealers: Paulson Investment Company, LLC (lead) Use of proceeds: Research and development including funding a Phase 1b/2 clinical trial, working capital and general corporate purposes | Jul 1, 2025 |
| Private placement of shares of common stock and accompanying warrants Announced: about US$2.25M · US$1.065 a share · Warrants at US$0.94 for 60 months · Paulson Investment Company, LLC Dealers: Paulson Investment Company, LLC (lead) Use of proceeds: Research and development activities, working capital and general corporate purposes | Jan 13, 2025 |